FORD KATHLEEN 4

What Happened Kathleen Ford, Chief Operating Officer of Kura Oncology (KURA), sold 1,813 shares on 2026-01-27 at $8.46 per share, generating $15,339 in proceeds. The Form 4 classifies the transaction as a sale and the filing indicates it was a sell-to-cover tied to RSU vesting.

Key Details

• Transaction date: 2026-01-27; Price: $8.46 per share; Shares sold: 1,813; Total proceeds: $15,339.
• Transaction type/code: Sale (S) — open market or private sale per the filing.
• Footnote F1: This was a sell-to-cover to satisfy taxes for RSUs that vested (RSU grant dated 1/26/22).
• Shares owned after the transaction: not provided in the excerpt of the filing.
• Filing date: 2026-01-27 (same day as the transaction), indicating a timely report.

Context A sell-to-cover is a common administrative transaction where a portion of vested restricted stock units are sold to cover tax withholding; it is routine and does not necessarily indicate a change in the insider’s view of the company. This filing reports only the tax-related sale tied to RSU vesting—no purchase or other disposition was reported in this filing.